亚洲社会药学

• 论文 • 上一篇    下一篇

Analysis on Drug Information Standard in China

Wang Yan, Wu Zhi’ang*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • 出版日期:2018-12-20 发布日期:2018-12-20

Analysis on Drug Information Standard in China

Wang Yan, Wu Zhi’ang*   

  1. School of Business Administration, Shenyang Pharmaceutical University, Shenyang 110016, China
  • Online:2018-12-20 Published:2018-12-20
  • Contact: Wu Zhi’ang, professor. Major research area: pharmaceutical management, pharmaceutical regulations, higher pharmacy education. Tel: 024-23986542, E-mail: wuzhiang66@163. com

摘要: Objective To find out how drug information standards will affect information sharing in China. Methods Four kinds of drug information standards from official sources were selected as research objects to analyze their existing problems respectively according to the government’s requirement and scope of strict drug control. Results and Conclusion There is lack of consensus among the four official sources of drug information standards, and each of them was designed to meet the needs of a specific sector. None of the standards can fully meet all needs. There is an urgent need to establish a coordination mechanism. Therefore, it is suggested that drug ontology should be set up to support information sharing.

关键词: drug information, standard, problem analysis

Abstract: Objective To find out how drug information standards will affect information sharing in China. Methods Four kinds of drug information standards from official sources were selected as research objects to analyze their existing problems respectively according to the government’s requirement and scope of strict drug control. Results and Conclusion There is lack of consensus among the four official sources of drug information standards, and each of them was designed to meet the needs of a specific sector. None of the standards can fully meet all needs. There is an urgent need to establish a coordination mechanism. Therefore, it is suggested that drug ontology should be set up to support information sharing.

Key words: drug information, standard, problem analysis